Systemic Therapy Type and Timing Effects on Radiation Necrosis Risk in HER2+ Breast Cancer Brain Metastases Patients Treated With Stereotactic Radiosurgery

Por Christine Park, Evan D. Buckley, Amanda E. D. Van Swearingen, Amanda E. D. Van Swearingen, Will Giles, James E. Herndon, James E. Herndon, John P. Kirkpatrick, John P. Kirkpatrick, John P. Kirkpatrick, Carey K. Anders, Carey K. Anders, Scott R. Floyd, Scott R. Floyd
Publicado em 2022-05-01

X-Ray Psoralen Activated Cancer Therapy (X-PACT).

Por Mark Oldham, Paul Yoon, Zak Fathi, Wayne F Beyer, Justus Adamson, Leihua Liu, David Alcorta, Wenle Xia, Takuya Osada, Congxiao Liu, Xiao Y Yang, Rebecca D Dodd, James E Herndon, Boyu Meng, David G Kirsch, H Kim Lyerly, Mark W Dewhirst, Peter Fecci, Harold Walder, Neil L Spector
Publicado em 2016-01-01

Long-Term Outcomes for Patients With Atypical or Malignant Meningiomas Treated With or Without Radiation Therapy: A 25-Year Retrospective Analysis of a Single-Institution Experienc...

Por Collin L. Kent, MD, Yvonne M. Mowery, MD, PhD, Olayode Babatunde, MD, Ato O. Wright, MD, Ian Barak, MS, Frances McSherry, MA, James E. Herndon, II, PhD, Allan H. Friedman, MD, Ali Zomorodi, MD, Katherine Peters, MD, PhD, Annick Desjardins, MD, Henry Friedman, MD, William Sperduto, MBS, John P. Kirkpatrick, MD, PhD
Publicado em 2022-05-01